To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients
Clinical trial NCT00258050 · COMPLETED
Trial details
- NCT number
- NCT00258050
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-21
- Primary completion
- 2007-02-08
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.